Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Keys to IBS care: Understanding medical options, where they ‘might be most effective’ Kate Burba
-
- Providing hope for IBS patients ‘is sometimes the greatest medication’ Brian E. Lacy, MD, PhD, FACG
- CRC incidence significantly higher among patients with cryptogenic pyogenic liver abscess Kate Burba
- FASCINATE-2 topline data: Denifanstat surpasses placebo for NASH with fibrosis at week 52
- FDA grants breakthrough device designation to Amadix’s blood test for colorectal cancer
- GI cancers contribute to 25% of global lifetime cancer risk, with highest risk for death Kate Burba
- Growing armamentarium of therapies for IBD has ‘truly revolutionized’ care Kate Burba
- Insurance-mandated barriers linked to negative clinical outcomes in IBD care Kate Burba
- Prophylactic probiotic ‘ineffective’ in mitigating GI permeability associated with aspirin Kate Burba
-
- Q&A: Zymfentra ‘gives patients an option’ for at-home maintenance therapy of IBD Monica Stonehill; Stephen B. Hanauer, MD
- Takeda’s Eohilia rebounds to win FDA approval as ‘first and only’ oral therapy for EoE
- Use of beta-blockers linked to acute kidney injury, mortality in decompensated cirrhosis Kate Burba
- VIDEO: ‘Dispel the myth of personal responsibility’ to combat obesity stigma Kate Burba; Catherine T. Hudson, MD
- VIDEO: Patient Voice winners driven to create global advocacy solutions, education for IBD Kate Burba; Tina Aswani-Omprakash; Madhura Balasubramaniam; Sharan Khela
- VIDEO: Reinforce self-care on individual, system levels for clinicians to ‘flourish’ Stacy A Ogbeide, PsyD, MS, MSCP, ABPP, CSOWM; Monica Stonehill
- VIDEO: Women, supportive allies must join forces to ‘break gender gap ceiling’ in GI Aline Charabaty, MD, AGAF, FACG; Monica Stonehill